An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma
Background: Gliomas are the most common and fatal malignant type of tumor of the central nervous system. RNA post-transcriptional modifications, as a frontier and hotspot in the field of epigenetics, have attracted increased attention in recent years. Among such modifications, methylation is most ab...
Main Authors: | Dongqi Shao, Yu Li, Junyong Wu, Binbin Zhang, Shan Xie, Xialin Zheng, Zhiquan Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.903117/full |
Similar Items
-
Development of a novel disulfidptosis-correlated m6A/m1A/m5C/m7G gene signature to predict prognosis and therapeutic response for lung adenocarcinoma patients by integrated machine-learning
by: Bilin Xu, et al.
Published: (2024-11-01) -
METTL3/YTDHF1 Stabilizes MTCH2 mRNA to Regulate Ferroptosis in Glioma Cells
by: Hongjun Liu, et al.
Published: (2025-02-01) -
M7G-related LncRNAs: A comprehensive analysis of the prognosis and immunity in glioma
by: Shuaishuai Wu, et al.
Published: (2022-11-01) -
Comprehensive analysis of m6A/m5C/m1A-related gene expression, immune infiltration, and sensitivity of antineoplastic drugs in glioma
by: Kai Zhao, et al.
Published: (2022-09-01) -
Establishment of a new molecular subtyping and prognostic signature with m6A/m5C/m1A/m7G regulatory genes for hepatocellular carcinoma
by: Ting Liu, et al.
Published: (2023-11-01)